CD34(+) cells augment endothelial cell differentiation of CD14(+) endothelial progenitor cells in vitro

Neovascularization by endothelial progenitor cells (EPC) for the treatment of ischaemic diseases has been a topic of intense research. The CD34(+) cell is often designated as EPC, because it contributes to repair of ischaemic injuries through neovascularization. However, incorporation of CD34(+) cel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cell Mol Med
Glavni autori: Krenning, G., van der Strate, B.W.A., Schipper, M., van Seijen, X.J. Gallego y, Fernandes, B.C.A., van Luyn, M.J.A., Harmsen, M.C.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2008
Teme:
Tissue Regeneration
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512353/
https://ncbi.nlm.nih.gov/pubmed/18752636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1582-4934.2008.00479.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items